Literature DB >> 16307439

Motor evoked potentials in a mouse model of chronic multiple sclerosis.

Stefano Amadio1, Stefano Pluchino, Elena Brini, Paolo Morana, Roberta Guerriero, Filippo Martinelli Boneschi, Giancarlo Comi, Paola Zaratin, Valeria Muzio, Ubaldo del Carro.   

Abstract

We tested cortical motor evoked potentials (cMEPs) as a quantitative marker for in vivo monitoring of corticospinal tract damage in a murine multiple sclerosis model (experimental autoimmune encephalomyelitis, EAE). The cMEPs, previously standardized in naive C57BL/6 developing and adult mice, were studied longitudinally in adult EAE mice. Central conduction times (CCTs) increased significantly shortly before the earliest clinical signs developed (10 days postimmunization, dpi), with peak delay in acute EAE (20-40 dpi). In clinically stable disease (80 dpi), CCTs did not increase further, but cMEP amplitude declined progressively, with complete loss in >80% of mice at 120 dpi. Increase in CCT correlated with presence of inflammatory infiltrates and demyelination in acute EAE, whereas small or absent cMEPs were associated with continuing axonal damage in clinically-stabilized disease and beyond (>80 dpi). These results demonstrate that cMEPs are a useful method for monitoring corticospinal tract function in chronic-progressive EAE, and provide insight into the pathological substrate of the condition.

Entities:  

Mesh:

Year:  2006        PMID: 16307439     DOI: 10.1002/mus.20463

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Intravenous injection of l-BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson-dementia complex.

Authors:  Ke-Wei Tian; Hong Jiang; Bei-Bei Wang; Fan Zhang; Shu Han
Journal:  Toxicol Res (Camb)       Date:  2015-11-10       Impact factor: 3.524

2.  The relationship between trunk and foot acceleration variability during walking shows minor changes in persons with multiple sclerosis.

Authors:  Jordan J Craig; Adam P Bruetsch; Sharon G Lynch; Jessie M Huisinga
Journal:  Clin Biomech (Bristol, Avon)       Date:  2017-07-28       Impact factor: 2.063

3.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

4.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Authors:  K Mangano; A Nicoletti; F Patti; M Donia; L Malaguarnera; S Signorelli; G Magro; V Muzio; B Greco; P Zaratin; P Meroni; M Zappia; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

5.  Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

Authors:  Alessandra Biffi; Alessia Capotondo; Stefania Fasano; Ubaldo del Carro; Sergio Marchesini; Hisaya Azuma; Maria Chiara Malaguti; Stefano Amadio; Riccardo Brambilla; Markus Grompe; Claudio Bordignon; Angelo Quattrini; Luigi Naldini
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

6.  Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells.

Authors:  Hong Jiang; Yuanyuan Zhang; Kewei Tian; Beibei Wang; Shu Han
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

7.  Persistent inflammation alters the function of the endogenous brain stem cell compartment.

Authors:  Stefano Pluchino; Luca Muzio; Jaime Imitola; Michela Deleidi; Clara Alfaro-Cervello; Giuliana Salani; Cristina Porcheri; Elena Brambilla; Francesca Cavasinni; Andrea Bergamaschi; Jose Manuel Garcia-Verdugo; Giancarlo Comi; Samia J Khoury; Gianvito Martino
Journal:  Brain       Date:  2008-08-30       Impact factor: 13.501

8.  Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE.

Authors:  Ke-Wei Tian; Yuan-Yuan Zhang; Hong Jiang; Shu Han
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.